Clinical Trial Update: Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of a gene therapy for critical limb ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease
• Ischemia
• Peripheral Vascular Disease
• Ulcers

Drugs mentioned

• Gene therapy (unnamed in excerpt)

Snippet

Sponsor: Beijing Northland Biotech. Co., Ltd. | Conditions: Arterial Occlusive Disease, Ulcers | Phase 2 | Status: COMPLETED